Cardiovascular Risk in Testicular Cancer Survivors Treated With Chemotherapy: Incidence, Significance, and Practice Implications

Barbara H. Zoltick

Linda A. Jacobs

David J. Vaughn

ONF 2005, 32(5), 1005-1012. DOI: 10.1188/05.ONF.1005-1012

Purpose/Objectives: To explore what is known regarding cardiovascular late effects of treatment, such as Raynaud phenomenon, hypertension, hyperlipidemia, and coronary artery disease as well as the risk for cardiovascular events experienced by patients with testicular cancer treated with chemotherapy.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.